Antares Pharma, Inc. EBITDA Margin 2010-2022 | ATRS

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Antares Pharma, Inc. (ATRS) over the last 10 years. The current EBITDA margin for Antares Pharma, Inc. as of March 31, 2022 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-03-31 $0.18B $0.06B 33.70%
2021-12-31 $0.18B $0.07B 38.04%
2021-09-30 $0.18B $0.03B 16.76%
2021-06-30 $0.17B $0.03B 15.79%
2021-03-31 $0.16B $0.02B 14.56%
2020-12-31 $0.15B $0.02B 10.74%
2020-09-30 $0.14B $0.02B 10.49%
2020-06-30 $0.14B $0.01B 8.76%
2020-03-31 $0.13B $0.01B 5.26%
2019-12-31 $0.12B $0.00B 3.25%
2019-09-30 $0.10B $0.01B 5.77%
2019-06-30 $0.09B $0.00B 2.27%
2019-03-31 $0.07B 0 0.00%
2018-12-31 $0.06B $-0.00B -1.56%
2018-09-30 $0.06B $-0.01B -20.34%
2018-06-30 $0.06B $-0.02B -26.79%
2018-03-31 $0.06B $-0.01B -25.45%
2017-12-31 $0.05B $-0.01B -24.07%
2017-09-30 $0.05B $-0.01B -25.93%
2017-06-30 $0.05B $-0.02B -30.77%
2017-03-31 $0.05B $-0.02B -39.22%
2016-12-31 $0.05B $-0.02B -45.10%
2016-09-30 $0.05B $-0.03B -51.02%
2016-06-30 $0.05B $-0.02B -51.06%
2016-03-31 $0.05B $-0.02B -38.78%
2015-12-31 $0.05B $-0.02B -40.00%
2015-09-30 $0.04B $-0.02B -53.66%
2015-06-30 $0.04B $-0.02B -64.86%
2015-03-31 $0.03B $-0.03B -110.34%
2014-12-31 $0.03B $-0.04B -134.62%
2014-09-30 $0.02B $-0.03B -134.78%
2014-06-30 $0.02B $-0.03B -136.36%
2014-03-31 $0.02B $-0.03B -118.18%
2013-12-31 $0.02B $-0.02B -90.91%
2013-09-30 $0.02B $-0.02B -82.61%
2013-06-30 $0.02B $-0.02B -69.57%
2013-03-31 $0.02B $-0.01B -63.64%
2012-12-31 $0.02B $-0.01B -45.83%
2012-09-30 $0.02B $-0.01B -26.09%
2012-06-30 $0.02B $-0.00B -19.05%
2012-03-31 $0.02B $-0.00B -15.00%
2011-12-31 $0.02B $-0.00B -23.53%
2011-09-30 $0.02B $-0.01B -33.33%
2011-06-30 $0.01B $-0.01B -42.86%
2011-03-31 $0.01B $-0.01B -46.15%
2010-12-31 $0.01B $-0.01B -58.33%
2010-09-30 $0.01B $-0.01B -66.67%
2010-06-30 $0.01B $-0.01B -72.73%
2010-03-31 $0.01B $-0.01B -80.00%
2009-12-31 $0.01B $-0.01B -88.89%